Leerink Partnrs Has Pessimistic View of MLTX FY2025 Earnings
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Stock analysts at Leerink Partnrs lowered their FY2025 earnings estimates for MoonLake Immunotherapeutics in a report issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now anticipates that the company will earn ($3.22) per share for the year, down from their prior forecast of ($3.06). The consensus […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Stock analysts at Leerink Partnrs lowered their FY2025 earnings estimates for MoonLake Immunotherapeutics in a report issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now anticipates that the company will earn ($3.22) per share for the year, down from their prior forecast of ($3.06). The consensus […]
